IP 253 (Ranitidine 150 mg)
Pill imprint IP 253 has been identified as Ranitidine hydrochloride 150 mg.
Ranitidine is used in the treatment of gerd; stomach ulcer; erosive esophagitis; gastric ulcer maintenance treatment; indigestion (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for IP 253 (Ranitidine 150 mg)
- 150 mg
- 9.00 mm
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Amneal Pharmaceuticals
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|66267-0188||Nucare Pharmaceuticals Inc (repackager)|
|68071-1321||Nucare Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about ranitidine
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...